ISDA: 4BBF

Deposition Date 2012-09-21

Release Date 2012-11-21

Last Version Date 2024-05-01

Entry Detail

PDB ID:

4BBF

Keywords:

TRANSFERASE

Title:

Aminoalkylpyrimidine Inhibitor Complexes with JAK2

Biological Source:

Source Organism(s):

HOMO SAPIENS (Taxon ID: 9606)

Expression System(s):

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.28

R-Value Work:

0.22

R-Value Observed:

0.23

Space Group:

P 1

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:TYROSINE-PROTEIN KINASE JAK2
Gene (Uniprot):JAK2
Mutagens:YES
Chain IDs:A, B, C, D
Chain Length:298
Number of Molecules:4
Biological Source:HOMO SAPIENS

UniProt ID:O60674 Pfam ID:PF07714 EC:2.7.10.2

Ligand Molecules

O19

Primary Citation

Sar and in Vivo Evaluation of 4-Aryl-2-Aminoalkylpyrimidines as Potent and Selective Janus Kinase 2 (Jak2) Inhibitors

Forsyth, T, Kearney, P.C, Kim, B.G, Johnson, H.W.B, Aay, N, Arcalas, A, Brown, D.S, Chan, V, Chen, J, Du, H, Epshteyn, S, Galan, A.A, Huynh, T.P, Ibrahim, M.A, Kane, B, Koltun, E, Mann, G, Meyr, L.E, Lee, M.S, Lewis, G.L, Noguchi, R.T, Pack, M, Ridgway, B.H, Shi, X, Takeuchi, C.S, Zu, P, Leahy, J.W, Nuss, J.M, Aoyama, R, Engst, S, Gendreau, S.B, Kassees, R, Li, J, Lin, S.-H, Martini, J.-F, Stout, T, Tong, P, Woolfrey, J, Zhang, W, Yu, P.Show

Bioorg.Med.Chem.Lett. 22 7653 ? (2012)

PMID: 23127890 DOI: 10.1016/J.BMCL.2012.10.007

Abstact

We report the discovery of a series of 4-aryl-2-aminoalkylpyrimidine derivatives as potent and selective JAK2 inhibitors. High throughput screening of our in-house compound library led to the identification of hit 1, from which optimization resulted in the discovery of highly potent and selective JAK2 inhibitors. Advanced lead 10d demonstrated a significant dose-dependent pharmacodynamic and antitumor effect in a mouse xenograft model. Based upon the desirable profile of 10d (XL019) it was advanced into clinical trials.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form